Starboard to vote against Bristol-Myers’ $74 billion deal for Celgene

February 28, 2019 admin Business News Comments Off on Starboard to vote against Bristol-Myers’ $74 billion deal for Celgene

Activist investor Starboard Value LP will vote against Bristol-Myers Squibb Co’s $74 billion acquisition of Celgene Corp, the hedge fund said on Thursday, the latest shareholder to come out against what would be the pharmaceutical world’s biggest ever takeover.

…read more

Source:: Reuters – Business News

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.